Kenny Roose

Gent, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that clamp the spike at its base.

Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that clamp the spike at its base.

Journal: Nature communications

Published: August 16, 2024

Single-domain antibodies directed against hemagglutinin and neuraminidase protect against influenza B viruses.

Single-domain antibodies directed against hemagglutinin and neuraminidase protect against influenza B viruses.

Journal: Nature communications

Published: July 03, 2024

Author Correction: Reverse engineering synthetic antiviral amyloids.

Author Correction: Reverse engineering synthetic antiviral amyloids.

Journal: Nature communications

Published: June 13, 2023

Integrating artificial intelligence-based epitope prediction in a SARS-CoV-2 antibody discovery pipeline: caution is warranted.

Integrating artificial intelligence-based epitope prediction in a SARS-CoV-2 antibody discovery pipeline: caution is warranted.

Journal: EBioMedicine

Published: May 01, 2023

An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models.

An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models.

Journal: Science translational medicine

Published: October 05, 2021

In Vivo Therapy with M2e-Specific IgG Selects for an Influenza A Virus Mutant with Delayed Matrix Protein 2 Expression.

In Vivo Therapy with M2e-Specific IgG Selects for an Influenza A Virus Mutant with Delayed Matrix Protein 2 Expression.

Journal: mBio

Published: July 13, 2021

STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters.

STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters.

Journal: Nature communications

Published: September 18, 2020

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies.

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies.

Journal: Cell

Published: June 13, 2020

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies.

Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies.

Journal: Cell

Published: March 25, 2020

The Opposing Effect of Type I IFN on the T Cell Response by Non-modified mRNA-Lipoplex Vaccines Is Determined by the Route of Administration.

The Opposing Effect of Type I IFN on the T Cell Response by Non-modified mRNA-Lipoplex Vaccines Is Determined by the Route of Administration.

Journal: Molecular therapy. Nucleic acids

Published: February 21, 2020

mRNA Encoding a Bispecific Single Domain Antibody Construct Protects against Influenza A Virus Infection in Mice.

mRNA Encoding a Bispecific Single Domain Antibody Construct Protects against Influenza A Virus Infection in Mice.

Journal: Molecular therapy. Nucleic acids

Published: February 18, 2020

Reverse engineering synthetic antiviral amyloids.

Reverse engineering synthetic antiviral amyloids.

Journal: Nature communications

Published: June 21, 2019

Showing 1-12 of 37

Last Updated: 09/26/2026